| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Luk, Ian Y. |
| dc.contributor.author | Jenkins, Laura J. |
| dc.contributor.author | Schoffer, Kael |
| dc.contributor.author | Ng, Irvin |
| dc.contributor.author | Tse, Janson W. T. |
| dc.contributor.author | Mouradov, Dmitri |
| dc.contributor.author | Arango Corro, Diego |
| dc.contributor.author | Dopeso Gonzalez, J Higinio |
| dc.date.accessioned | 2022-11-04T08:43:58Z |
| dc.date.available | 2022-11-04T08:43:58Z |
| dc.date.issued | 2022-11 |
| dc.identifier.citation | Luk IY, Jenkins LJ, Schoffer KL, Ng I, Tse JWT, Mouradov D, et al. Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression. Cell Death Differ. 2022 Nov;29:2288–02. |
| dc.identifier.issn | 1476-5403 |
| dc.identifier.uri | https://hdl.handle.net/11351/8392 |
| dc.description | Epigenética; Proteínas supresoras de tumores |
| dc.language.iso | eng |
| dc.publisher | Springer Nature |
| dc.relation.ispartofseries | Cell Death & Differentiation;29 |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Epigenètica |
| dc.subject | Còlon - Càncer - Aspectes genètics |
| dc.subject | Recte - Càncer - Aspectes genètics |
| dc.subject.mesh | Colorectal Neoplasms |
| dc.subject.mesh | /genetics |
| dc.subject.mesh | Transcription Factors |
| dc.subject.mesh | Epigenesis, Genetic |
| dc.title | Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1038/s41418-022-01016-w |
| dc.subject.decs | neoplasias colorrectales |
| dc.subject.decs | /genética |
| dc.subject.decs | factores de transcripción |
| dc.subject.decs | epigénesis genética |
| dc.relation.publishversion | https://doi.org/10.1038/s41418-022-01016-w |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Luk IY, Tse JWT] Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia. La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia. Department of Medicine, University of Melbourne, Melbourne, VIC, Australia. [Jenkins LJ, Schoffer KL, Ng I] Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia. La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia. [Mouradov D] Personalised Oncology Division, The Walter and Eliza Hall Institute of Medial Research, Parkville, VIC, Australia. Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia. [Arango D] Grup de Recerca Biomèdica en Tumors de l'Aparell Digestiu, CIBBIM-Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Group of Molecular Oncology, Biomedical Research institute of Lleida (IRBLleida), Lleida, Spain. [Dopeso H] Grup de Recerca Biomèdica en Tumors de l'Aparell Digestiu, CIBBIM-Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain |
| dc.identifier.pmid | 35606410 |
| dc.identifier.wos | 000800969900001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |